PATENT CLAIM ANALYSIS

Application Number: 16170208
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["506", "009000"]

Abstract:
A method of using an exchange-induced remnant magnetization (EXIRM) technique for label free detection of short strands of nucleotides and cancer biomarkers, such as DNA and microRNA strands, DNA/RNA-binding biomarkers, and cancer-specific antigens, with high sensitivity, high specificity, and broad dynamic range. The method may provide a label-free approach aimed to facilitate high reliability, and to require a minimum amount of biochemical reagents.

Claim (Index 6):
The method of  claim 5 , wherein step f comprises measuring the change in magnetic signal (\u0394B), optionally the method further comprising calculating the molar concentration of said third nucleotide strand, wherein said concentration is linearly related to \u0394B.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.39623
- Patent Class: 506.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12835869', '11958180', '15450675', '15209090', '14571142']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6225906829256319
- 35 USC 102 Novelty (BERT): 0.5141755587256054
- Combined Prediction Score: 0.6117491705056293
- Mean Citation Score: 276.811358
- Max Citation Score: 279.44
- Similarity Product: 172.26573808670045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test